MDR-TB in Pakistan: Challenges, efforts, and recommendations.

Khan, Mahad Ahmed; Bilal, Wajeeha; Asim, Hanzla; Rahmat, Zainab Syyeda; Essar, Mohammad Yasir; Ahmad, Shoaib

Khan, Mahad Ahmed; Bilal, Wajeeha; Asim, Hanzla; Rahmat, Zainab Syyeda; Essar, Mohammad Yasir; Ahmad, Shoaib.

Afiliação

Khan MA; Dow University of Health Sciences, Pakistan.
Bilal W; Dow University of Health Sciences, Pakistan.
Asim H; Dow University of Health Sciences, Pakistan.
Rahmat ZS; Dow University of Health Sciences, Pakistan.
Essar MY; Kabul University of Medical Sciences, Kabul, Afghanistan.
Ahmad S; District Head Quarters Teaching Hospital, Faisalabad, Pakistan.

Ann Med Surg (Lond) ; 79: 104009, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35860138

Palavras-chave

COVID-19; MDR, multiple drug resistance; MDR-TB; PMDT, Programmatic Management of Drug-Resistant Tuberculosis; Pakistan; Tuberculosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Paquistão País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google